Gdansk, Poland

Joanna Jakobkiewicz-Banecka

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Instytut Farmaceutyczny. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joanna Jakobkiewicz-Banecka. Retrieved from https://idiyas.com/inventor/joanna-jakobkiewicz-banecka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Gdańsk, PL (2012)
  • Gdansk, PL (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joanna Jakobkiewicz-Banecka: Innovator in Mucopolysaccharidosis Treatment

Introduction

Joanna Jakobkiewicz-Banecka is a prominent inventor based in Gdansk, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mucopolysaccharidoses. With two patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Her latest patents focus on the use of isoflavones for treating mucopolysaccharidoses. The method involves administering a therapeutically effective amount of a natural isoflavone, its derivatives, or pharmaceutically acceptable salts to patients in need of treatment. The pharmaceutical compositions she developed include a natural isoflavone, which is crucial for effective treatment.

Career Highlights

Joanna works at the Instytut Farmaceutyczny, where she continues to advance her research and development efforts. Her dedication to improving patient outcomes through innovative treatments is evident in her work.

Collaborations

She collaborates with notable colleagues, including Grzegorz Grynkiewicz and Grzegorz Wegrzyn, to enhance the impact of her research.

Conclusion

Joanna Jakobkiewicz-Banecka's contributions to the field of pharmaceuticals, particularly in treating mucopolysaccharidoses, highlight her role as an influential inventor. Her innovative approaches and collaborative efforts are set to make a lasting impact on patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…